Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia

More on Lipid and ceramide metabolism

• Cumulative non-HDL cholesterol links to cardiovascular risk

  Journal of Diabetes and Metabolic Disorders · 4 Oct 2026

• Social context predicts heart risks despite normal biomarkers

  medRxiv · 4 Oct 2026

• Small HDL particle count is linked to lower mortality

  medRxiv · 4 Oct 2026

• Martin-Hopkins LDL equation best predicts cardiovascular risk

  Circulation Population Health and Outcomes · 4 Oct 2026